Wednesday, May 9, 2007

St. Jude wins FDA OK for new pacemaker lead

(Reuters) - The company said the lead, which attaches to a cardiac pacemaker, is the first of its kind, designed to provide more accurate sensing of the right atrium, the upper chamber of the heart.

The lead incorporates a new tip that reduces extraneous signals from the heart's ventricles, or the lower chambers, that can interfere with a pacemaker's sensing capabilities.


Read more at Reuters.com Government Filings News

No comments: